Abstract:
The expression of mRNAs encoding a human nongastric proton pump (ATP1AL1) in the colorectum was investigated. The real-time PCR gave significant levels of signals not only in the distal part of human colon and rectum, but also in the proximal part of the colon. ATP1AL1 mRNA was overexpressed in 12 out of 20 human colorectal adenocarcinomas compared with the level in the accompanying normal mucosa. It is noted that astonishing levels of the mRNA overexpression were found in 4 carcinomas, which were detected even by Northern blot. The very high levels of ATP1AL1 mRNA expression in some cancer tissues may be connected to an unknown specific pathophysiological condition. [ old]; Japan SLC, Shizuoka, Japan) as previously described [12, 13] . The animals had free access to water and food until the day of the experiment. They were killed rapidly by stunning and cervical dislocation. All procedures were performed in accordance with the guidelines presented by the Animal Care and Use Committee of Toyama Medical and Pharmaceutical University.
Total RNAs from the human and rat tissues were prepared as described elsewhere [14, 15] , and 10 g of total RNA was separated on 1% agarose/formamide gel and transferred onto a nylon membrane (Zetaprobe GT, Bio-Rad, Hercules, CA, USA). The readyto-use multiple tissue Northern blots ( A Northern blot analysis with the 32 P-labeled cDNA probe was performed as previously described [14, 15] . For the detection of rat nongastric H ϩ ,K ϩ -ATPase, the membrane was hybridized with a 32 P-labeled 572 bp ATP1AL1 fragment, which is 86% identical to that of rat nongastric H 
Results and Discussion
First, we checked the distribution of nongastric H -ATPase mRNA in the colon of 7-week-old rats was essentially the same as that in 7-month-old rats, suggesting that the aging has no effect on an expression of the nongastric H ϩ ,K ϩ -ATPase. Next, the distribution of ATP1AL1 mRNA in human tissues was examined by Northern blot analysis. So far, ATP1AL1 mRNA in several particular tissues and cells has been detected with RT-PCR (reverse transcription-polymerase chain reaction) [16] [17] [18] , but the result of Northern blot analysis for determining the size of ATP1AL1 mRNA has not been reported. cluding several parts of the colon, give no positive signal of 4.0 kb. An expression of Na ϩ ,K ϩ -ATPase mRNA of 3.9 kb was observed in all the tissues tested ( Fig. 2A) .
Using real-time PCR (TaqMan assay), we further checked the expression of ATP1AL1 mRNA in the human normal colonic mucosa obtained from the surgical resection of patients with colorectal cancer. For positive and negative control, we examined the mRNA expression in the kidney and stomach, respectively. A significant expression of ATP1AL1 mRNA could be observed in the colorectum and kidney, but not in stomach, by this more-sensitive method (Fig. 2B) . The pattern of distribution of ATP1AL1 mRNA in the human colon (Fig. 2B) is apparently different from that of nongastric H ϩ ,K ϩ -ATPase mRNA in the rat colon ( Fig. 1) : that is, ATP1AL1 mRNA is expressed not only in the distal part of the colon (sigmoid colon) and rectum, but also in the proximal part of the colon (ascending colon).
The expression levels of ATP1AL1 mRNA in the normal human colon seem to be less significant than those of rat nongastric H ϩ ,K ϩ -ATPase mRNA, which is abundantly expressed in the distal colon. We therefore speculate that ATP1AL1 may not be a counterpart of rat nongastric H The normal mucosa was obtained from the patients with colorectal cancer as described in Methods. The ages (years; meanϮSE) and sex (M, male-F, female) of patients are 72Ϯ3, 5M-3F (nϭ8; ascending colon), 67Ϯ2, 6M-1F (nϭ 7; transverse colon), 68Ϯ 4, 3M-6F (nϭ9; sigmoid colon) and, 68Ϯ3, 8M-6F (nϭ14; rectum). In each, the arbitrary value for the amount of ATP1AL1 mRNA was divided by that of GAPDH mRNA. For the negative control experiment, normal parts of gastric mucosa from 3 patients with stomach cancer (70Ϯ3 years, 1M-2F) were used. As a positive control, human kidney mRNA (Clontech Laboratories) was used. Age (years) and sex (M, male; F, female) of the patient, the size (cm ϫ cm) and location of the carcinoma (C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon; R, rectum), and stage of the carcinoma according to the TNM clinical classification by the International Union Against Cancer are shown. 12 out of 20 carcinomas compared with the level in normal mucosa (Fig. 3A left and B) . The significant signals of ATP1AL1 mRNA of 4.0 kb were clearly observed in several carcinomas even by Northern blot (Fig. 3C) . The overexpression of ATP1AL1 mRNA was not due to a reflection of stimulated angiogenesis (increased number of blood cells) in the carcinoma, because no significant expression of ATP1AL1 was observed in peripheral leukocytes and liver ( Fig. 2A) . The expression of ATP1AL1 mRNA was decreased in 8 out of 20 carcinomas (Fig. 3A right and B) . The change (increase or decrease) in the mRNA level of ATP1AL1 does not seem to correlate with the age and sex of the patient, the location and size of the carcinoma, and the clinical stage (Table 1 and Fig. 3 ).
The pathophysiological function of ATP1AL1 in various colorectal carcinomas is unknown. Apparently, further study to clarify the mechanism of increase and decrease in the level of ATP1AL1 mRNA in the carcinoma is necessary. In summary, we found that ATP1AL1 mRNA is weakly but widely expressed in all the parts of normal colonic mucosa. The very high levels of ATP1AL1 mRNA expression in some cancer tissues may be connected to an unknown specific pathophysiological condition.
